Literature DB >> 8039666

The membrane destabilising action of the antibacterial agent chlorhexidine.

K Barrett-Bee1, L Newboult, S Edwards.   

Abstract

The antibacterial agent chlorhexidine has long been used as an agent for medical antisepsis. This compound is a membrane active agent which probably has its major antibacterial action by interference with the function of cellular membranes. The results demonstrated an inhibition of oxygen utilisation by bacteria which was related to falls in cellular ATP levels. There was an effect on the outer membranes of Gram-negative bacteria which allowed the release of periplasmic enzymes. The inner membrane was not ruptured but its functionality was breached and there was an inhibition of active uptake of small molecules which did not appear to be related to cellular ATP levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039666     DOI: 10.1111/j.1574-6968.1994.tb06896.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  13 in total

1.  Microscopic and spectroscopic analyses of chlorhexidine tolerance in Delftia acidovorans biofilms.

Authors:  Tara Rema; John R Lawrence; James J Dynes; Adam P Hitchcock; Darren R Korber
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

2.  Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms.

Authors:  Tom Coenye; Heleen Van Acker; Elke Peeters; Andrea Sass; Silvia Buroni; Giovanna Riccardi; Eshwar Mahenthiralingam
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

3.  Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm.

Authors:  Peter A Suci; Bonnie J Tyler
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  Role of the chymotrypsin-like membrane-associated proteinase from Treponema denticola ATCC 35405 in inactivation of bioactive peptides.

Authors:  P L Mäkinen; K K Mäkinen; S A Syed
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Minimizing human infection from Escherichia coli O157:H7 using GUMBOS.

Authors:  Marsha R Cole; Min Li; Ravirajsinh Jadeja; Bilal El-Zahab; Daniel Hayes; Jeffery A Hobden; Marlene E Janes; Isiah M Warner
Journal:  J Antimicrob Chemother       Date:  2013-02-26       Impact factor: 5.790

6.  Potassium loss from chlorhexidine-treated bacterial pathogens is time- and concentration-dependent and variable between species.

Authors:  Noelle H O'Driscoll; Olga Labovitiadi; T P Tim Cushnie; Kerr H Matthews; Andrew J Lamb
Journal:  Curr Microbiol       Date:  2013-08-09       Impact factor: 2.188

7.  Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli.

Authors:  Hon-Yeung Cheung; Matthew Man-Kin Wong; Sau-Ha Cheung; Longman Yimin Liang; Yun-Wah Lam; Sung-Kay Chiu
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

Review 8.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  Comparative analysis of Salmonella susceptibility and tolerance to the biocide chlorhexidine identifies a complex cellular defense network.

Authors:  Orla Condell; Karen A Power; Kristian Händler; Sarah Finn; Aine Sheridan; Kjell Sergeant; Jenny Renaut; Catherine M Burgess; Jay C D Hinton; Jarlath E Nally; Séamus Fanning
Journal:  Front Microbiol       Date:  2014-08-01       Impact factor: 5.640

10.  Potentiation of isoniazid activity against Mycobacterium tuberculosis by melatonin.

Authors:  I Wiid; E Hoal-van Helden; D Hon; C Lombard; P van Helden
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.